Very precarious to state your silly speculation as fact. Besides if that were the case insiders would have sold before Yellen made her comments about the biotech sector a few months ago.
You are so full of garbage. Insiders exercise options all the time. If they were bailing then why not sell everything? No one sold more than 9% of their holdings and all of them still have the majority of their shares.
I would argue that maybe they are selling some now to avoid any potential problems selling prior to a buyout (run-up) or other big news that will make the pps jump. Maybe for tax purposes? Maybe due to a pre-determined stock/financial plan.
I don't find it too unusual at all.
Also, Ebola is very scary and I'm not sure if Fabry patients will continue to buy the drugs if Ebola threatens our way of life.
I removed my last response after I realized what the insiders obviously did. Which was exercise their options and sell those shares. Sorry, not the sharpest tool in the shed.
You'll have to check the filings, but 5 insiders exercised and sold a good chunk. Including CFO William Baird. No big deal though, imo.
Great answer. thx. Some questions
1. When you say "the product" r u referring to Amigal?
2. Looking at a substantial increase in rev for 12/15,but a concomitant rise in expenses; eps remains at -.23 for 12/15. What say you?
My only concern is that the share price might fizzle again if we don't hear a favorable news tomorrow. I hope I'm wrong.